Prestwich Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

Prestwich Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.1.5.71 04934939 Board of Directors 1.12.18 30.11.19 30.11.19 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure049349392018-11-30049349392019-11-30049349392018-12-012019-11-30049349392017-11-30049349392017-12-012018-11-30049349392018-11-3004934939ns15:EnglandWales2018-12-012019-11-3004934939ns14:PoundSterling2018-12-012019-11-3004934939ns10:Director12018-12-012019-11-3004934939ns10:PrivateLimitedCompanyLtd2018-12-012019-11-3004934939ns10:SmallEntities2018-12-012019-11-3004934939ns10:AuditExempt-NoAccountantsReport2018-12-012019-11-3004934939ns10:SmallCompaniesRegimeForDirectorsReport2018-12-012019-11-3004934939ns10:SmallCompaniesRegimeForAccounts2018-12-012019-11-3004934939ns10:FullAccounts2018-12-012019-11-3004934939ns10:Director22018-12-012019-11-3004934939ns10:Director32018-12-012019-11-3004934939ns10:Director42018-12-012019-11-3004934939ns10:CompanySecretary12018-12-012019-11-3004934939ns10:RegisteredOffice2018-12-012019-11-3004934939ns5:CurrentFinancialInstruments2019-11-3004934939ns5:CurrentFinancialInstruments2018-11-3004934939ns5:ShareCapital2019-11-3004934939ns5:ShareCapital2018-11-3004934939ns5:SharePremium2019-11-3004934939ns5:SharePremium2018-11-3004934939ns5:RetainedEarningsAccumulatedLosses2019-11-3004934939ns5:RetainedEarningsAccumulatedLosses2018-11-3004934939ns5:LeaseholdImprovements2018-12-012019-11-3004934939ns5:PlantMachinery2018-12-012019-11-3004934939ns5:FurnitureFittings2018-12-012019-11-3004934939ns5:LeaseholdImprovements2018-11-3004934939ns5:PlantMachinery2018-11-3004934939ns5:FurnitureFittings2018-11-3004934939ns5:LeaseholdImprovements2019-11-3004934939ns5:PlantMachinery2019-11-3004934939ns5:FurnitureFittings2019-11-3004934939ns5:LeaseholdImprovements2018-11-3004934939ns5:PlantMachinery2018-11-3004934939ns5:FurnitureFittings2018-11-3004934939ns5:CostValuation2018-11-3004934939ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-11-3004934939ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-11-30
REGISTERED NUMBER: 04934939 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2019

for

PRESTWICH PHARMACY LIMITED

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Contents of the Financial Statements
for the Year Ended 30 November 2019










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PRESTWICH PHARMACY LIMITED

Company Information
for the Year Ended 30 November 2019







DIRECTORS: Mr F G McCaul
Mrs H Hughes
Mr H Hughes
Mr M Williams



SECRETARY: Mrs H Hughes



REGISTERED OFFICE: Century Buildings
14 St. Mary's Parsonage
Manchester
M3 2DF



REGISTERED NUMBER: 04934939 (England and Wales)



ACCOUNTANTS: BTMR Limited
Century Buildings
14 St Mary's Parsonage
Manchester
M3 2DF



BANKERS: Lloyds TSB Bank Plc
Burnley Branch
Burnley
Lancashire

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Balance Sheet
30 November 2019

30.11.19 30.11.18
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 12,652 22,940
Investments 5 162,981 162,981
175,633 185,921

CURRENT ASSETS
Stocks 177,662 157,820
Debtors 6 237,082 161,836
Cash at bank and in hand 30,133 19,798
444,877 339,454
CREDITORS
Amounts falling due within one year 7 427,759 429,448
NET CURRENT ASSETS/(LIABILITIES) 17,118 (89,994 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

192,751

95,927

CAPITAL AND RESERVES
Called up share capital 10,004 10,004
Share premium 92,668 92,668
Retained earnings 90,079 (6,745 )
SHAREHOLDERS' FUNDS 192,751 95,927

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 September 2020 and
were signed on its behalf by:





Mr F G McCaul - Director


PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements
for the Year Ended 30 November 2019


1. STATUTORY INFORMATION

Prestwich Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is accounted for as revenue when, and to the extent that, the company obtains a right to consideration
in exchange for its performance of its obligations under the sales contract with the customer. The amount
reported as revenue is the fair value of the right to consideration - usually the price specified in the contractual
arrangement net of discounts and net of VAT, and after any allowance for credit risk and other uncertainties.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 33% on cost
Fixtures and fittings - 33% on cost

Tangible fixed assets are initially recorded at cost.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual
arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any
contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 26 (2018 - 24 ) .

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2019


4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1 December 2018 554,610 246,793 285,694 1,087,097
Additions - - 1,746 1,746
At 30 November 2019 554,610 246,793 287,440 1,088,843
DEPRECIATION
At 1 December 2018 554,610 244,774 264,773 1,064,157
Charge for year - 511 11,523 12,034
At 30 November 2019 554,610 245,285 276,296 1,076,191
NET BOOK VALUE
At 30 November 2019 - 1,508 11,144 12,652
At 30 November 2018 - 2,019 20,921 22,940

5. FIXED ASSET INVESTMENTS
Shares in
subsidiary
undertaki
ngs
£   
COST
At 1 December 2018
and 30 November 2019 162,981
NET BOOK VALUE
At 30 November 2019 162,981
At 30 November 2018 162,981

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.19 30.11.18
£    £   
Trade debtors 188,611 110,504
Other debtors 48,471 51,332
237,082 161,836

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.19 30.11.18
£    £   
Trade creditors 254,136 276,871
Taxation and social security 31,907 49,831
Other creditors 141,716 102,746
427,759 429,448

8. ULTIMATE CONTROLLING PARTY

There is no controlling party